Trials / Completed
CompletedNCT00881244
Study of AS1411 in Advanced Solid Tumours
Phase I Open Label Study of AS1411 in Advanced Solid Tumours
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Antisoma Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Phase I open label study of AS1411 in advanced solid tumours. Objectives include determining the MTD and DLT of AS1411, to determine the PK profile of AS1411 and to obtain preliminary evidence of clinical and biological responses to AS1411 therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AS1411 | I.v. 4-7 days, 1-40 mg/kg/day |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2006-06-01
- Completion
- 2007-02-01
- First posted
- 2009-04-15
- Last updated
- 2009-04-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00881244. Inclusion in this directory is not an endorsement.